|
시장보고서
상품코드
1949189
방사선 종양학 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)Global Radiation Oncology Market Size, Share, Trends & Growth Analysis Report 2026-2034 |
||||||
방사선 종양학 시장 규모는 2025년 102억 7,000만 달러에서 2026-2034년 CAGR 7.23%로 성장하여 2034년에는 192억 5,000만 달러에 이를 것으로 예측되고 있습니다.
방사선 종양학 시장은 암 발생률 증가와 효과적인 치료법에 대한 수요 증가를 배경으로 큰 폭의 성장이 예상됩니다. 전 세계적으로 암 발생률이 지속적으로 증가함에 따라 첨단 방사선 치료 솔루션의 필요성이 점점 더 중요해지고 있습니다. 방사선 종양학은 외부조사치료, 근접조사치료, 정위적 방사선 수술 등 다양한 기술을 포함하고 있으며, 이들 모두 다양한 암종의 종합적인 치료에 필수적입니다. 세기변조방사선치료(IMRT), 영상유도방사선치료(IGRT)와 같은 첨단 기술의 통합으로 치료의 정확성과 유효성을 향상시켜 환자의 치료 성적을 개선하고 부작용을 최소화하고 있습니다.
또한, 방사선 종양학 기술의 발전은 시장 내 혁신을 촉진하고 있습니다. 양성자 치료 및 기타 입자선 치료의 개발은 종양을 효과적으로 치료하면서 정상 조직을 보존하는 표적 방사선을 제공함으로써 암 치료에 혁명을 일으키고 있습니다. 이러한 첨단 치료법은 특히 소아 환자나 중요 구조물에 가까운 종양을 가진 환자들에게 도움이 될 수 있습니다. 방사선 종양학 분야의 새로운 응용 및 기술 연구가 계속되는 가운데, 치료 효과와 환자 안전성이 향상될 것으로 기대되는 만큼 시장은 더욱 확대될 것으로 예측됩니다.
또한, 맞춤형 의료에 대한 관심이 높아지면서 방사선 종양학의 전망을 형성하고 있습니다. 의료진이 유전자 프로파일링과 분자 프로파일링을 기반으로 환자 개개인에 맞는 치료를 추구함에 따라, 개인별 맞춤 치료 계획에 따른 방사선 치료 수요는 증가할 것으로 예측됩니다. 이러한 추세는 치료 효과를 높이기 위해 방사선 치료를 면역치료나 표적치료와 병행하는 병용요법의 맥락에서 특히 중요합니다. 방사선 종양학 시장이 계속 진화하는 가운데, 기술 혁신의 융합, 개인화된 치료 접근법, 그리고 환자 결과 개선에 대한 집중은 향후 방사선 종양학 시장 전망 궤도를 형성하는 데 중요한 역할을 할 것입니다.
목차
제1장 서론
제2장 주요 요약
제3장 시장 변수, 동향, 프레임워크
제4장 세계의 방사선 종양학 시장 : 제품 유형별
제5장 세계의 방사선 종양학 시장 : 용도별
제6장 세계의 방사선 종양학 시장 : 최종사용자별
제7장 세계의 방사선 종양학 시장 : 지역별
제8장 경쟁 구도
제9장 기업 개요
LSH 26.03.20The Radiation Oncology Market size is expected to reach USD 19.25 Billion in 2034 from USD 10.27 Billion (2025) growing at a CAGR of 7.23% during 2026-2034.
The radiation oncology market is poised for significant growth, driven by the increasing incidence of cancer and the rising demand for effective treatment modalities. As cancer rates continue to escalate globally, the need for advanced radiation therapy solutions is becoming more critical. Radiation oncology encompasses a range of techniques, including external beam radiation therapy, brachytherapy, and stereotactic radiosurgery, all of which are essential in the comprehensive management of various cancer types. The integration of cutting-edge technologies, such as intensity-modulated radiation therapy (IMRT) and image-guided radiation therapy (IGRT), is enhancing the precision and effectiveness of treatment, thereby improving patient outcomes and minimizing side effects.
Moreover, advancements in radiation oncology technologies are driving innovation within the market. The development of proton therapy and other particle therapies is revolutionizing cancer treatment by providing targeted radiation that spares healthy tissues while effectively treating tumors. These advanced modalities are particularly beneficial for pediatric patients and those with tumors located near critical structures. As research continues to explore new applications and techniques in radiation oncology, the market is likely to expand further, fueled by the promise of improved therapeutic efficacy and patient safety.
Additionally, the growing emphasis on personalized medicine is shaping the radiation oncology landscape. As healthcare providers increasingly seek to tailor treatments to individual patients based on genetic and molecular profiling, the demand for radiation therapy that aligns with personalized treatment plans is expected to rise. This trend is particularly relevant in the context of combination therapies, where radiation is used alongside immunotherapy or targeted therapies to enhance treatment effectiveness. As the radiation oncology market continues to evolve, the convergence of technological advancements, personalized treatment approaches, and a focus on improving patient outcomes will play a crucial role in shaping its future trajectory.
Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:
Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.
Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.
Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.
Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.
Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.
Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.
Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.
MARKET SEGMENTATION
By Product Type
- External Beam Radiation Therapy
- Internal Beam Radiation Therapy
- Systemic Radiation Therapy
By Application
- Breast Cancer
- Lung Cancer
- Prostate Cancer
- Colorectal Cancer
- Head and Neck Cancer
- Others
By End-User
- Hospitals
- Ambulatory Radiotherapy Centers
- Cancer Research Institutes
- Others
COMPANIES PROFILED
- Siemens Healthineers, GE Healthcare, Philips Healthcare, Varian Medical Systems, Elekta, Hitachi Medical Corporation, IBA Worldwide, Accuray Incorporated, Advanced Accelerator Applications, Nordion Inc
We can customise the report as per your requriements
TABLE OF CONTENTS
Chapter 1. PREFACE
- 1.1. Market Segmentation & Scope
- 1.2. Market Definition
- 1.3. Information Procurement
- 1.3.1 Information Analysis
- 1.3.2 Market Formulation & Data Visualization
- 1.3.3 Data Validation & Publishing
- 1.4. Research Scope and Assumptions
- 1.4.1 List of Data Sources
Chapter 2. EXECUTIVE SUMMARY
- 2.1. Market Snapshot
- 2.2. Segmental Outlook
- 2.3. Competitive Outlook
Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK
- 3.1. Market Lineage Outlook
- 3.2. Penetration & Growth Prospect Mapping
- 3.3. Value Chain Analysis
- 3.4. Regulatory Framework
- 3.4.1 Standards & Compliance
- 3.4.2 Regulatory Impact Analysis
- 3.5. Market Dynamics
- 3.5.1 Market Drivers
- 3.5.2 Market Restraints
- 3.5.3 Market Opportunities
- 3.5.4 Market Challenges
- 3.6. Porter's Five Forces Analysis
- 3.7. PESTLE Analysis
Chapter 4. GLOBAL RADIATION ONCOLOGY MARKET: BY PRODUCT TYPE 2022-2034 (USD MN)
- 4.1. Market Analysis, Insights and Forecast Product Type
- 4.2. External Beam Radiation Therapy Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 4.3. Internal Beam Radiation Therapy Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 4.4. Systemic Radiation Therapy Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 5. GLOBAL RADIATION ONCOLOGY MARKET: BY APPLICATION 2022-2034 (USD MN)
- 5.1. Market Analysis, Insights and Forecast Application
- 5.2. Breast Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 5.3. Lung Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 5.4. Prostate Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 5.5. Colorectal Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 5.6. Head and Neck Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 5.7. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 6. GLOBAL RADIATION ONCOLOGY MARKET: BY END-USER 2022-2034 (USD MN)
- 6.1. Market Analysis, Insights and Forecast End-user
- 6.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 6.3. Ambulatory Radiotherapy Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 6.4. Cancer Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 6.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 7. GLOBAL RADIATION ONCOLOGY MARKET: BY REGION 2022-2034(USD MN)
- 7.1. Regional Outlook
- 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 7.2.1 By Product Type
- 7.2.2 By Application
- 7.2.3 By End-user
- 7.2.4 United States
- 7.2.5 Canada
- 7.2.6 Mexico
- 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 7.3.1 By Product Type
- 7.3.2 By Application
- 7.3.3 By End-user
- 7.3.4 United Kingdom
- 7.3.5 France
- 7.3.6 Germany
- 7.3.7 Italy
- 7.3.8 Russia
- 7.3.9 Rest Of Europe
- 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 7.4.1 By Product Type
- 7.4.2 By Application
- 7.4.3 By End-user
- 7.4.4 India
- 7.4.5 Japan
- 7.4.6 South Korea
- 7.4.7 Australia
- 7.4.8 South East Asia
- 7.4.9 Rest Of Asia Pacific
- 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 7.5.1 By Product Type
- 7.5.2 By Application
- 7.5.3 By End-user
- 7.5.4 Brazil
- 7.5.5 Argentina
- 7.5.6 Peru
- 7.5.7 Chile
- 7.5.8 South East Asia
- 7.5.9 Rest of Latin America
- 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 7.6.1 By Product Type
- 7.6.2 By Application
- 7.6.3 By End-user
- 7.6.4 Saudi Arabia
- 7.6.5 UAE
- 7.6.6 Israel
- 7.6.7 South Africa
- 7.6.8 Rest of the Middle East And Africa
Chapter 8. COMPETITIVE LANDSCAPE
- 8.1. Recent Developments
- 8.2. Company Categorization
- 8.3. Supply Chain & Channel Partners (based on availability)
- 8.4. Market Share & Positioning Analysis (based on availability)
- 8.5. Vendor Landscape (based on availability)
- 8.6. Strategy Mapping
Chapter 9. COMPANY PROFILES OF GLOBAL RADIATION ONCOLOGY INDUSTRY
- 9.1. Top Companies Market Share Analysis
- 9.2. Company Profiles
- 9.2.1 Siemens Healthineers
- 9.2.2 GE Healthcare
- 9.2.3 Philips Healthcare
- 9.2.4 Varian Medical Systems
- 9.2.5 Elekta
- 9.2.6 Hitachi Medical Corporation
- 9.2.7 IBA Worldwide
- 9.2.8 Accuray Incorporated
- 9.2.9 Advanced Accelerator Applications
- 9.2.10 Nordion Inc
